← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Omega Fund Iv, L.P. sold $1.0M of Replimune Group, Inc.

Director and 10% owner

Sold$1,041,021
$33.57Price
31,015Shares
−1%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Thu, Nov 4. Filed Mon, Nov 8, 9:14 AM ET, before the open. Not investment advice.